Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions

Article ID	Journal	Published Year	Pages	File Type
8402071	Advanced Drug Delivery Reviews	2018	38 Pages	PDF

Keywords

MCP-1 cysteine-rich protein 61 CCN1 CXCR2 CX3CR1 GM-CSF HAART PLGA MYD88 IL-6 natural killer HIV/AIDS interleukin-6 highly active antiretroviral therapy Immunosuppression granulocyte-macrophage colony-stimulating factor Infection Vascular endothelial growth factor Vascular Endothelial Growth Factor (VEGF)Immunity Tissue engineering human immunodeficiency virus/acquired immunodeficiency syndrome myeloid differentiation primary response gene 88 Monocyte chemotactic protein-1 Regenerative medicine poly(lactide-co-glycolide)Immunodeficient

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Biotechnology

Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions

Authors

Alexander M. Tatara, Dimitrios P. Kontoyiannis, Antonios G. Mikos,